Recommendations of the Panel on Cost-Effectiveness in Health and Medicine

Cited by (1,004)

Items 601–700 of 1,004

1. Applications of cost-effectiveness methodologies in behavioral medicine.
   Robert M. Kaplan, Erik J. Groessl · 2002 · Journal of Consulting and Clinical Psychology
2. Cost-Effectiveness Analysis of Periacetabular Osteotomy
   Emile Sharifi, Husham Sharifi, Saam Morshed, Kevin John Bozic, Mohammad Diab · 2008 · Journal of Bone and Joint Surgery
3. Screening and Prevention of Venous Thromboembolism in Critically Ill Patients: A Decision Analysis and Economic Evaluation
   Sachin Sud, Nicole Mittmann, Deborah J. Cook, William H Geerts, Brian Chan, Peter Dodek, Michael K. Gould, Gordon Henry Guyatt, Yaseen M. Arabi, Robert Fowler · 2011 · American Journal of Respiratory and Critical Care Medicine
4. US Insurance Program's Experience With a Multigene Assay for Early-Stage Breast Cancer
   John C Hornberger, Rebecca Chien, Katie Krebs, Louis I. Hochheiser · 2011 · Journal of Oncology Practice
5. Laparoscopic Versus Open Cholecystectomy: A Cost–Effectiveness Analysis at Rwanda Military Hospital
   Allison Silverstein, Ainhoa Costas‐Chavarri, Mussa R. Gakwaya, Joseph Lule, Swagoto Mukhopadhyay, John Gerard Meara, Mark G. Shrime · 2016 · World Journal of Surgery
6. ACCF/AHA/ACP 2009 Competence and Training Statement: A Curriculum on Prevention of Cardiovascular Disease
   C. Noel Bairey Merz, Mark J. Alberts, Gary John Balady, Christie Mitchell Ballantyne, Kathy A. Berra, Henry R. Black, Roger Scott Blumenthal, Michael H. Davidson, Sara B. Fazio, Keith C. Ferdinand et al. · 2009 · Journal of the American College of Cardiology
7. Prescribing Antiepileptic Drugs
   Barbara C. Jobst, Gregory L. Holmes · 2004 · CNS Drugs
8. Updated Evaluation of the Cost-effectiveness of Lung Volume Reduction Surgery
   Scott David Ramsey, Annie Laurie Shroyer, Sean D. Sullivan, Douglas E. Wood · 2007 · CHEST Journal
9. An economic evaluation of irbesartan in the treatment of patients with type 2 diabetes, hypertension and nephropathy: cost-effectiveness of Irbesartan in Diabetic Nephropathy Trial (IDNT) in the Belgian and French settings
   Andrew John Palmer · 2003 · Nephrology Dialysis Transplantation
10. Economic evaluation of alcohol treatment services
    Michael T. French · 2000 · Evaluation and Program Planning
11. Cost-effectiveness of memantine in moderate-to-severe Alzheimer's disease patients receiving donepezil
    Weycker, Derek, Taneja, Charu, Edelsberg, John, Haim Erder, M., Schmitt, Frederick A., Setyawan, Juliana, Oster, Gerry · 2007 · Current Medical Research and Opinion
12. Design, execution, interpretation, and reporting of economic evaluation studies in obstetrics.
    A. Vintzileos, T. Beazoglou · 2004 · American Journal of Obstetrics and Gynecology
13. Laboratory Monitoring to Guide Switching Antiretroviral Therapy in Resource-Limited Settings: Clinical Benefits and Cost-Effectiveness
    April D. Kimmel, Milton C. Weinstein, Xavier Anglaret, Sue J. Goldie, Elena Losina, Yazdan Yazdanpanah, Eugène Messou, Kara L. Cotich, Rochelle P. Walensky, Kenneth A. Freedberg · 2010 · JAIDS Journal of Acquired Immune Deficiency Syndromes
14. Cost-Effectiveness of Fixed-Dose Combination of Isosorbide Dinitrate and Hydralazine Therapy for Blacks With Heart Failure
    Derek C. Angus, Walter T. Linde‐Zwirble, S. William Tam, Jalal K. Ghali, Michael L. Sabolinski, Victor G. Villagra, Wolfgang C. Winkelmayer­, Manuel Worcel · 2005 · Circulation
15. Novel Oral Anticoagulants Versus Warfarin Therapy at Various Levels of Anticoagulation Control in Atrial Fibrillation—A Cost-Effectiveness Analysis
    Joyce H. S. You · 2013 · Journal of General Internal Medicine
16. Medical and Economic Long-term Effects of B-Type Natriuretic Peptide Testing in Patients with Acute Dyspnea
    Tobias Breidthardt, Kirsten Laule, Anne-Henny Strohmeyer, Christian J. A. Schindler, Sophie Meier, Michael Fischer, André Scholer, Markus Noveanu, Michael Christ, André Paul Perruchoud et al. · 2007 · Clinical Chemistry
17. Comparative cost-minimisation of oral and intravenous chemotherapy for first-line treatment of non-small cell lung cancer in the UK NHS system
    K Le Lay, Eric Myon, Samuel Luke Hill, Lionel Riou França, David Alexander Scott, M. Sidhu, David J. Dunlop, R Launois · 2007 · The European Journal of Health Economics
18. Effects of Arthroscopy for Femoroacetabular Impingement Syndrome on Quality of Life and Economic Outcomes
    Richard C. “Chad” Mather, Shane Jay Nho, Andrew E. Federer, Berna Demiralp, Jennifer T. Nguyen, Asha Saavoss, Michael Jonathan Salata, Marc J. Philippon, Asheesh Bedi, Christopher Michael Larson et al. · 2018 · The American Journal of Sports Medicine
19. Can Utility-Weighted Health-Related Quality-of-Life Estimates Capture Health Effects of Quality Improvement for Depression?
    Cathy Donald Sherbourne, Jürgen Unützer, Michael Schoenbaum, Naihua Duan, Leslie Andrew Lenert, Roland Sturm, Kenneth Brooks Wells · 2001 · Medical Care
20. The 23-Valent Pneumococcal Polysaccharide Vaccine. Part II. A Cost-Effectiveness Analysis for Invasive Disease in the Elderly in England and Wales
    Alessia Melegaro, W. John Edmunds · 2004 · European Journal of Epidemiology
21. The Pediatric Quality Appraisal Questionnaire: An Instrument for Evaluation of the Pediatric Health Economics Literature
    Wendy J. Ungar, Maria Teresa Santos · 2003 · Value in Health
22. Cost-effectiveness of intense insulin treatment after acute myocardial infarction in patients with diabetes mellitus. Results from the DIGAMI study
    Bjorn Almbrand · 2000 · European Heart Journal
23. Assessing the Performance of Utility Techniques in the Absence of a Gold Standard
    R. Brian Giesler, Carol M. Ashton, Baruch A. Brody, Margaret M. Byrne, Karon Frances Cook, Jane M. Geraci, Makoto Hanita, Julianne Souchek, Nelda P. Wray · 1999 · Medical Care
24. Comparative Cost-Effectiveness of Clinic, Home, or Ambulatory Blood Pressure Measurement for Hypertension Diagnosis in US Adults: A Modeling Study
    Beyhaghi, Hadi, Viera, Anthony J. · 2019 · Hypertension
25. Assessment of transparency of cost estimates in economic evaluations of patient safety programmes
    Haruhisa Fukuda, Yuichi Imanaka · 2009 · Journal of Evaluation in Clinical Practice
26. Paper Standard Gamble: The Reliability of a Paper Questionnaire to Assess Utility
    Benjamin Littenberg, Steven R. Partilo, Anita L. Licata, Michael W. Kattan · 2003 · Medical Decision Making
27. An Economic Evaluation of the Expanded Food and Nutrition Education Program
    Jamie Dollahite, Donald Kenkel, C. Scott Thompson · 2008 · Journal of Nutrition Education and Behavior
28. Economic Evaluation of Strategies to Reduce Sudden Cardiac Death in Young Athletes
    Michael Schoenbaum, Peter Denchev, Benedetto Vitiello, Jonathan R. Kaltman · 2012 · PEDIATRICS
29. The Clinical Role and Cost-Effectiveness of Long-Acting Antiretroviral Therapy
    Eric L. Ross, Milton C. Weinstein, Bruce R. Schackman, Paul Edward Sax, A. David Paltiel, Rochelle P. Walensky, Kenneth A. Freedberg, Elena Losina · 2015 · Clinical Infectious Diseases
30. Evaluation for Blunt Cerebrovascular Injury: Review of the Literature and a Cost-Effectiveness Analysis
    Ajay Malhotra, Xiao Juan Wu, Vivek B. Kalra, Joseph Schindler, Charles Christian Matouk, Howard Paul Forman · 2015 · American Journal of Neuroradiology
31. Cost-effectiveness of colorectal cancer screening in Germany: current endoscopic and fecal testing strategies versus plasma methylated Septin 9 DNA
    Uri Ladabaum, Lourdes Alvarez-Osorio, Thomas Rösch, Bernd Brueggenjuergen · 2014 · Endoscopy International Open
32. Initial Evaluation of Rectal Bleeding in Young Persons: A Cost-Effectiveness Analysis
    James D. Lewis, Alphonso Brown, A. Russell Localio, Jerome Sanford Schwartz · 2002 · Annals of Internal Medicine
33. Transforming growth factor-?1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma
    Yukihiro Hasegawa, Shingo Takanashi, Yutaka Kanehira, Takao Tsushima, Tadashi Imai, Ken Okumura · 2001 · Cancer
34. Modeling the Cost-Effectiveness of Colorectal Cancer Screening: Policy Guidance Based on Patient Preferences and Compliance
    Sujha Subramanian, Georgiy Bobashev, Robert J. Morris · 2009 · Cancer Epidemiology Biomarkers & Prevention
35. At the Threshold: Defining Clinically Meaningful Resistance Thresholds for Antibiotic Choice in Community‐Acquired Pneumonia
    Nick Daneman, Donald E. Low, Allison McGeer, Karen A. Green, David N. Fisman · 2008 · Clinical Infectious Diseases
36. Interpreting Cost Analyses of Clinical Interventions
    E. Andrew Balas · 1998 · JAMA
37. The economic value of primary prophylaxis using pegfilgrastim compared with filgrastim in patients with breast cancer in the UK
    Zhimei Liu, Quan V. Doan, Jennifer K. Malin, Robert Leonar · 2009 · Applied Health Economics and Health Policy
38. Collecting and analysing cost data for complex public health trials: reflections on practice
    Neha Batura, Anni‐Maria Pulkki‐Brännström, Priya Agrawal, Archana Bagra, Hassan Haghparast‐Bidgoli, Fiammetta Maria Bozzani, Tim Colbourn, Giulia Greco, Md. Tanvir Hossain, Rajesh Kumar Sinha et al. · 2014 · Global Health Action
39. Economic and health effect of full adherence to controller therapy in adults with uncontrolled asthma: A simulation study
    Zafar Zafarí, Larry David Lynd, J. Mark FitzGerald, Mohsen Sadatsafavi · 2014 · Journal of Allergy and Clinical Immunology
40. An economic evaluation of Herceptin® in adjuvant setting: the Breast Cancer International Research Group 006 trial
    Mattias Neyt, Johan Albrecht, V.F.J. Cocquyt · 2005 · Annals of Oncology
41. Cost-effectiveness Analysis of the Diagnosis of Meniscus Tears
    Richard C. “Chad” Mather, William E. Jr. Garrett, Brian J. Cole, Kristen Elizabeth Hussey, Michael Paul Bolognesi, Tally Lassiter, Lori A. Orlando · 2014 · The American Journal of Sports Medicine
42. Cost-Effectiveness Analysis of Brentuximab Vedotin With Chemotherapy in Newly Diagnosed Stage III and IV Hodgkin Lymphoma
    Scott F. Huntington, Gottfried von Keudell, Amy J. Davidoff, Cary Philip Gross, Sapna A. Prasad · 2018 · Journal of Clinical Oncology
43. Hospital Discharge to Care Facility
    Mohamed Y. Rady, Daniel J. Johnson · 2004 · CHEST Journal
44. The cost‐effectiveness of reducing donor exposures with single‐donor versus pooled random‐donor platelets
    Ileana Lopez‐Plaza, Joel L. Weissfeld, Darrell J. Triulzi · 1999 · Transfusion
45. Statistical Method for Predicting When Patients Should Be Ready on the Day of Surgery
    Franklin Dexter, Rodney D. Traub · 2000 · Anesthesiology
46. The need for mental health services research focusing on poor young women.
    Jeanne M. Miranda, B. Green · 1999 · Journal of Mental Health Policy and Economics
47. The financial implications of coverage of smoking cessation treatment by managed care organizations
    Warner, Kenneth E., Mendez, David, Smith, Dean G. · 2004 · INQUIRY: The Journal of Health Care Organization, Provision, and Financing
48. A Cost Analysis of the American Board of Internal Medicine's Maintenance-of-Certification Program
    Alexander T. Sandhu, R. Adams Dudley, Dhruv S. Kazi · 2015 · Annals of Internal Medicine
49. The Cost–Utility of Total Hip Arthroplasty: Earlier Intervention, Improved Economics
    Carlos J. Lavernia, David A. Iacobelli, Larry Brooks, Jesus M. Villa · 2015 · The Journal of Arthroplasty
50. Cost-Effectiveness Analysis: A Proposal of New Reporting Standards in Statistical Analysis
    Heejung Bang, Hongwei Zhao · 2014 · Journal of Biopharmaceutical Statistics
51. Evaluating the cost‐effectiveness of cancer patient navigation programs: Conceptual and practical issues
    Scott David Ramsey, Elizabeth Whitley, Victoria Warren‐Mears, June M. McKoy, Rachel M. Everhart, Robert J. Caswell, Kevin A Fiscella, Thelma C. Hurd, Tracy Ann Battaglia, Jeanne S. Mandelblatt · 2009 · Cancer
52. Cost-Effectiveness of Fluocinolone Acetonide Implant versus Systemic Therapy for Noninfectious Intermediate, Posterior, and Panuveitis
    Elizabeth A. Sugar, Janet T. Holbrook, John H. Kempen, Alyce E. Burke, Lea T. Drye, Jennifer E. Thorne, Thomas A. Louis, Douglas A. Jabs, Michael M. Altaweel, Kevin D. Frick · 2014 · Ophthalmology
53. Fondaparinux for Isolated Superficial Vein Thrombosis of the Legs
    Marc Blondon, Marc Righini, Henri Bounameaux, David Leroy Veenstra · 2011 · CHEST Journal
54. The By-Band study: gastric bypass or adjustable gastric band surgery to treat morbid obesity: study protocol for a multi-centre randomised controlled trial with an internal pilot phase
    Chris A. Rogers, Richard Welbourn, James Patrick Byrne, Jenny Donovan, Barnaby C Reeves, Sarah Wordsworth, Robert Charles Andrews, Janice L. Thompson, Paul Roderick, David Mahon et al. · 2014 · Trials
55. Cost-Effectiveness Analysis of Rituximab Combined with CHOP for Treatment of Diffuse Large B-Cell Lymphoma
    Jennie H. Best, John C Hornberger, Stephen John Proctor, Louis F Omnes, F Jost · 2005 · Value in Health
56. Health‐Related Quality of Life in Children With Autoimmune Liver Disease
    Reema Gulati, Kadakkal R. Radhakrishnan, Vera F. Hupertz, Robert Wyllie, Naim Alkhouri, Sarah E. Worley, Ariel E. Feldstein · 2013 · Journal of Pediatric Gastroenterology and Nutrition
57. The total costs of a displaced femoral neck fracture: comparison of internal fixation and total hip replacement
    Torsten Johansson, Margareta Bachrach‐Lindström, Per Aspenberg, Dick Jonsson, Ola Wahlström · 2005 · International Orthopaedics
58. Cost-effectiveness of cardiac rehabilitation program delivery models in patients at varying cardiac risk, reason for referral, and sex
    Sophia Papadakis, Robert D. Reid, Doug Coyle, Louise J. Beaton, Douglas Angus, Neil Oldridge · 2008 · European Journal of Cardiovascular Prevention & Rehabilitation
59. The model-based cost-effectiveness analysis of 1-year adjuvant trastuzumab treatment: based on 2-year follow-up HERA trial data
    Takeru Shiroiwa, Takashi Fukuda, Kojiro Shimozuma, Yasuo Ohashi, Kiichiro Tsutani · 2007 · Breast Cancer Research and Treatment
60. Cost‐Effectiveness Analysis of Introduction of Rapid, Alternative Methods to Identify Multidrug‐Resistant Tuberculosis in Middle‐Income Countries
    Carlos Acuña-Villaorduña, Anna Vassall, Germán Henostroza, Carlos Seas, Humberto Guerra, Lucy Vásquez, Nora Morcillo, Juan Carlos Saravia, Richard O’Brien, Mark D. Perkins et al. · 2008 · Clinical Infectious Diseases
61. Trastuzumab in adjuvant breast cancer therapy. A model based cost-effectiveness analysis
    Jan Norum, Jan Abel Olsen, E. Wist, Per Eystein Lønning · 2006 · Acta Oncologica
62. Prophylactic splenectomy and cholecystectomy in mild hereditary spherocytosis: analyzing the decision in different clinical scenarios
    Monia Marchetti, Quaglini, Barosi · 1998 · Journal of Internal Medicine
63. Cost‐benefit Analysis for the Treatment of Severe Obesity
    Louis F. Martin, Steven White, Walter Lindstrom · 1998 · World Journal of Surgery
64. Adherence to the iDSI reference case among published cost-per-DALY averted studies
    Joanna G. Emerson, Ari D. Panzer, Joshua T. Cohen, Kalipso Chalkidou, Yot Teerawattananon, Mark John Sculpher, Thomas Wilkinson, Damian G. Walker, Peter J. Neumann, David D. Kim · 2019 · PLoS ONE
65. Cost Effectiveness of ‘On Demand’ Hiv Pre‐Exposure Prophylaxis for Non‐Injection Drug‐Using Men Who Have Sex with Men in Canada
    Estelle Ouellet, Madéleine Durand, Jason R. Guertin, Jacques LeLorier, Cecile L. Tremblay · 2015 · Canadian Journal of Infectious Diseases and Medical Microbiology
66. Understanding cost-effectiveness
    Marya D. Zilberberg, Andrew F. Shorr · 2010 · Clinical Microbiology and Infection
67. Effectiveness and Cost-Effectiveness of Blood Pressure Screening in Adolescents in the United States
    Y. Claire Wang, Angela M. Cheung, Kirsten B. Bibbins-Domingo, Lisa A. Prosser, Nancy R. Cook, Lee Goldman, Matthew W. Gillman · 2010 · The Journal of Pediatrics
68. Wearable cardioverter-defibrillator for prevention of sudden cardiac death after infected implantable cardioverter-defibrillator removal: A cost-effectiveness evaluation
    Christopher A. Healy, Roger G. Carrillo · 2015 · Heart Rhythm
69. The value of comparative effectiveness research: Projected return on investment of the RxPONDER trial (SWOG S1007)
    William Bruce Wong, Scott David Ramsey, William Eric Barlow, Louis P. Garrison, David Leroy Veenstra · 2012 · Contemporary Clinical Trials
70. Cost-effectiveness of antiretroviral regimens in the World Health Organization's treatment guidelines: a South African analysis
    Eran Bendavid, Philip Grant, Annie Talbot, Douglas K Owens, Andrew R. Zolopa · 2010 · AIDS
71. Cost-effectiveness of malaria internittent preventive treatment in infants (IPTi) in Mozambique and the United Republic of Tanzania
    Guy Hutton · 2009 · Bulletin of the World Health Organization
72. Reporting and dissemination of industry versus non-profit sponsored economic analyses of six novel drugs used in oncology
    K.S. Knox, Jared R. Adams, Benjamin Djulbegović, T J Stinson, C. Tomori, Charles L. Bennet · 2000 · Annals of Oncology
73. Early Childhood Inpatient Costs of Critical Congenital Heart Disease
    Nelangi Marie Pinto, Norman J. Waitzman, Richard E. Nelson, L. LuAnn Minich, Sergey V. Krikov, Lorenzo D. Botto · 2018 · The Journal of Pediatrics
74. Use of B-type natriuretic peptide for the management of women with dyspnea
    Christian Eugen Mueller, Kirsten Laule-Kilian, André Scholer, Barbara Frana, Daniel Rodríguez, Christian J. A. Schindler, Stephan C. U. Marsch, André Paul Perruchoud · 2004 · The American Journal of Cardiology
75. Putting a Lid on Injury Costs
    Wendy B. Max, Brad Stark, Sharon Root · 1998
76. Morbidité et coût des infections à rotavirus en France
    Hugues Melliez, Pierre‐Yves Boëlle, Sabine Baron, Yves Mouton, Yazdan Yazdanpanah · 2005 · Médecine et Maladies Infectieuses
77. The cost-effectiveness of vaccinating chronic hepatitis C patients against hepatitis A1
    R. Jake Jacobs, Raymond S. Koff, Allen S. Meyerhoff · 2002 · The American Journal of Gastroenterology
78. Cost‐effectiveness of patient navigation to increase adherence with screening colonoscopy among minority individuals
    Uri Ladabaum, Ajitha Mannalithara, Lina M. Jandorf, Steven H. Itzkowitz · 2014 · Cancer
79. Cost-effectiveness analysis of a cervical cancer vaccine in five Latin American countries
    Lisandro Damián Colantonio, Jorge Alberto Gomez, Nadia Demarteau, Baudouin A. Standaert, Andrés Pichón-Rivière, Federico Augustovski · 2009 · Vaccine
80. Cost-Effectiveness of Adjuvanted Influenza Vaccination of Healthy Children 6 to 60 Months of Age
    Monia Marchetti, Ursula Maria Kuehnel, Giorgio Lorenzo Colombo, Susanna Esposito, Nicola Principi · 2007 · Human Vaccines
81. The 2‐Year Cost‐Effectiveness of 3 options to Treat Lumbar Spinal Stenosis Patients
    Belinda L. Udeh, Shrif J. Costandi, Jarrod E. Dalton, Raktim K. Ghosh, Hani F. Yousef, Nagy A. Mekhail · 2014 · Pain Practice
82. Twenty Years of Cost-effectiveness Analysis in Medical Imaging: Are We Improving?
    Hansel J. Otero, Frank J. Rybicki, Dan Greenberg, Peter J. Neumann · 2008 · Radiology
83. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost-utility analysis
    Julio Cesar Furlan, K.K. Chan, Guillermo A. Sandoval, K. C. K. Lam, Christopher A. Klinger, Roy A. Patchell, Audrey Laporte, Michael George Fehlings · 2012 · Neuro-Oncology
84. Integrating Mortality and Morbidity Outcomes
    Niall D. Ferguson, Damon C. Scales, Ruxandra L Pinto, Mary Elizabeth Wilcox, Deborah J. Cook, Gordon Henry Guyatt, Holger Jens Schünemann, John C. Marshall, Margaret S. Herridge, Maureen O. Meade · 2012 · American Journal of Respiratory and Critical Care Medicine
85. Effectiveness and Cost-effectiveness of Thrombolysis in Submassive Pulmonary Embolism
    Daniella J. Perlroth · 2007 · Archives of Internal Medicine
86. Lobectomy is a more Cost-Effective Option than Total Thyroidectomy for 1 to 4 cm Papillary Thyroid Carcinoma that do not Possess Clinically Recognizable High-Risk Features
    Brian Hung‐Hin Lang, Carlos King Ho Wong · 2016 · Annals of Surgical Oncology
87. The Cost Effectiveness of Early Treatment with Fluticasone Propionate 250 μ g Twice a Day in Subjects with Obstructive Airway Disease
    GUIDO VAN DEN BOOM, Maureen Rutten‐van Mölken, Johan Molema, PRASANNA R. S. TIRIMANNA, Chris van Weel, Onno C. P. van Schayck · 2001 · American Journal of Respiratory and Critical Care Medicine
88. Modelling Approaches
    Bart M. S. Heeg, Joep Damen, Erik Buskens, Sue Caleo, Frank de Charro, Ben A. van Hout · 2008 · PharmacoEconomics
89. Cost-effectiveness of recombinant human activated protein C and the influence of severity of illness in the treatment of patients with severe sepsis
    Robert Fowler, Marya Hill-Popper, John Stasinos, Constantia Petrou, Gillian D Sanders, Alan M. Garber · 2003 · Journal of Critical Care
90. Cost-Effectiveness of Hepatic Metastasectomy in Patients With Metastatic Colorectal Carcinoma
    G. Scott Gazelle, M. G. Myriam Hunink, Karen M. Kuntz, Pamela M. McMahon, Elkan F. Halpern, Molly T. Beinfeld, Jessica S. Lester, Kenneth K. Tanabe, Milton C. Weinstein · 2003 · Annals of Surgery
91. Re-examination of the Cost-Effectiveness of Surgical Versus Medical Therapy in Patients With Gastroesophageal Reflux Disease: The Value of Long-Term Data Collection
    Miguel R. Arguedas, Gustavo R. Heudebert, Joshua C. Klapow, Robert M. Centor, Mohamad A. Eloubeidi, C. Mel Wilcox, Stuart Jon Spechler, VA Cooperative Study Group · 2004 · The American Journal of Gastroenterology
92. Cost-Effectiveness of Uterine Artery Embolization and Hysterectomy for Uterine Fibroids
    Molly T. Beinfeld, Johanna L. Bosch, Keith Isaacson, G. Scott Gazelle · 2004 · Radiology
93. Reduced costs with bisoprolol treatment for heart failure; an economic analysis of the second Cardiac Insufficiency Bisoprolol Study (CIBIS-II)
    P Bacquet, E Levy, A McGuire, John J.V. McMurray, JL Merot, B Paschen, Willem J. Remme, TD Szucs, W Klein, W Brunhuber et al. · 2001 · European Heart Journal
94. Effects of naloxone distribution alone or in combination with addiction treatment with or without pre-exposure prophylaxis for HIV prevention in people who inject drugs: a cost-effectiveness modelling study
    Uyei, Jennifer, Fiellin, David A, Buchelli, Marianne, Rodriguez-Santana, Ramon, Braithwaite, R Scott · 2017 · The Lancet Public Health
95. Cost-effectiveness analysis of bevacizumab combined with chemotherapy for the treatment of metastatic colorectal cancer in Japan
    Takeru Shiroiwa, Takashi Fukuda, Kiichiro Tsutani · 2007 · Clinical Therapeutics
96. Cost-Effectiveness Analysis of KRAS Testing and Cetuximab as Last-Line Therapy for Colorectal Cancer
    Takeru Shiroiwa, Yoshiharu Motoo, Kiichiro Tsutani · 2010 · Molecular Diagnosis & Therapy
97. Cost-Effectiveness of Strategies to Improve HIV Testing and Receipt of Results: Economic Analysis of a Randomized Controlled Trial
    Gillian D Sanders, Henry D. Anaya, Steven M. Asch, Tuyen Hoang, Joya F. Golden, Ahmed M. Bayoumi, Douglas K Owens · 2010 · Journal of General Internal Medicine
98. Cost‐Effectiveness of Supervised Exercise, Stenting, and Optimal Medical Care for Claudication: Results From the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) Trial
    Matthew R. Reynolds, Patricia K. Apruzzese, Benjamin Zev Galper, Timothy P. Murphy, Alan T. Hirsch, Donald E. Cutlip, Emile R. Mohler, Judith G. Regensteiner, David J. Cohen · 2014 · Journal of the American Heart Association
99. Cost-effectiveness of World Health Organization 2010 Guidelines for Prevention of Mother-to-Child HIV Transmission in Zimbabwe
    Andrea L. Ciaranello, Freddy Pérez, Barbara Engelsmann, Rochelle P. Walensky, Angela Mushavi, Asinath Rusibamayila, Jo Keatinge, Ji-Eun Park, Matthews Maruva, Rodrigo Cerda et al. · 2012 · Clinical Infectious Diseases
100. The Effect of Pulmonary Artery Catheter Use on Costs and Long-Term Outcomes of Acute Lung Injury
     Gilles Clermont, Lan Kong, Lisa A. Weissfeld, Judith R. Lave, Gordon David Rubenfeld, Mark S. Roberts, Alfred F. Connors, Gordon R. Bernard, Bruce Thompson, Arthur P. Wheeler et al. · 2011 · PLoS ONE